Principles of microRNA involvement in human cancers

Chinese Journal of Cancer

Volumn 30, Issue 11, 2011, Pages 739-748

  Ling, Hui ^a   Zhang, Wei ^a   Calin, George A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Biomarker; Cancer; MicroRNA; Mutation; Non coding RNA

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; BRCA1 PROTEIN; BRCA2 PROTEIN; MICRORNA; MICRORNA 141; MICRORNA 143; MICRORNA 145; MICRORNA 15; MICRORNA 155; MICRORNA 15A; MICRORNA 16; MICRORNA 16 1; MICRORNA 17; MICRORNA 181; MICRORNA 18A; MICRORNA 19A; MICRORNA 20A; MICRORNA 21; MICRORNA 210; MICRORNA 221; MICRORNA 222; MICRORNA 29; MICRORNA 34; MICRORNA 34A; PROTEIN MCL 1; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ACUTE GRANULOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BLOOD LEVEL; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CARCINOGENESIS; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL EVALUATION; DIAGNOSTIC VALUE; DISEASE MARKER; DRUG TARGETING; ERYTHROLEUKEMIA; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; GENE TARGETING; GENETIC PREDISPOSITION; HUMAN; LIVER CANCER; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; ONCOGENE; PROGNOSIS; REVIEW; RNA ANALYSIS; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALS; DRUG DELIVERY SYSTEMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC THERAPY; HUMANS; MICRORNAS; MUTATION; NEOPLASMS; RNA, LONG UNTRANSLATED;

EID: 80355135204     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.011.10243     Document Type: Review

References (69)

1. Ambros V. The evolution of our thinking about micro RNAs [J]. Nat Med, 2008,14(10):1036-1040.
2. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? [J]. Nat Rev Genet, 2008,9(2):102-114.
3. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation [J]. Science, 2007,318(5858):1931-1934.
4. Tay Y, Zhang J, Thomson AM, et al. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation [J]. Nature, 2008,455(7216):1124-1128.
5. Hwang HW, Wentzel EA, Mendell JT. A hexanucleotide element directs microRNA nuclear import [J]. Science, 2007,315(5808): 97-100.
6. Place RF, Li LC, Pookot D, et al. MicroRNA-37 3 induces expression of genes with complementary promoter sequences [J]. Proc Natl Acad Sci U S A, 2008,105(5):1608-1613.
7. Eiring AM, Harb JG, Neviani P, et al. miR-32 8 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts [J]. Cell, 2010,140(5):652-665.
8. Calin GA, Croce CM. MicroRNA-cancer connection: the beginning of a new tale [J]. Cancer Res, 2006,66 (15):7390-7394.
9. Calin GA, Croce CM. MicroRNA signatures in human cancers [J]. Nat Rev Cancer, 2006,6(11):857-866.
10. Small EM, Frost RJ, Olson EN. MicroRNAs add a new dimension to cardiovascular disease [J]. Circulation, 2010,121 (8):1022-1032.
11. Edwards JK, Pasqualini R, Arap W, et al. MicroRNAs and ultraconserved genes as diagnostic markers and therapeutic targets in cancer and cardiovascular diseases [J]. J Cardiovasc Transl Res, 2010,3(3):271-279.
12. Liu CG, Calin GA, Volinia S, et al. MicroRNA expression profiling using microarrays [J]. Nat Protoc, 2008,3(4):563-578.
13. Spizzo R, Nicoloso MS, Croce CM, et al. Snapshot: microRNAs in cancer [J]. Cell, 2009,137(3):586-586.
14. Zenz T, Mohr J, Eldering E, et al. miR-34 a as part of the resistance network in chronic lymphocytic leukemia [J]. Blood, 2009,113(16):3801-3808.
15. Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. [J]. Proc Natl Acad Sci U S A, 2004,101(9):2999-3004.
16. Esteller M. Epigenetics in cancer [J]. N Engl J Med, 2008,358 (11):1148-1159.
17. Melo SA, Esteller M. A precursor microRNA in a cancer cell nucleus: get me out of here! [J]. Cell Cycle, 2011,10(6):922-925.
18. Chang TC, Wentzel EA, Kent OA, et al. Transactivation of mir- 34a by p53 broadly influences gene expression and promotes apoptosis [J]. Mol Cell, 2007,26(5):745-752.
19. Chang TC, Yu D, Lee YS, et al. Widespread microRNA repression by myc contributes to tumorigenesis [J]. Nat Genet, 2008,40(1):43-50.
20. Lodygin D, Tarasov V, Epanchintsev A, et al. Inactivation of miR-34 a by aberrant CPG methylation in multiple types of cancer [J]. Cell Cycle, 2008,7(16):2591-2600.
21. Wei JS, Song YK, Durinck S, et al. The MYCN oncogene is a direct target of miR-34 a [J]. Oncogene, 2008,27 (39):5204-5213.
22. He L, He X, Lowe SW, et al. MicroRNAs join the p53 network-another piece in the tumour-suppression puzzle [J]. Nat Rev Cancer, 2007,7(11):819-822.
23. He L, He X, Lim LP, et al. A microRNA component of the p53tumour suppressor network [J]. Nature, 2007,447(7148):1130-1134.
24. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10 b in breast cancer [J]. Nature, 2007,449(7163):682-688.
25. Nicoloso MS, Spizzo R, Shimizu M, et al. MicroRNAs-the micro steering wheel of tumour metastases [J]. Nat Rev Cancer, 2009,9(4):293-302.
26. Calin GA, Cimmino A, Fabbri M, et al. miR-15 a and miR-16 -1 cluster functions in human leukemia [J]. Proc Natl Acad Sci U S A, 2008,105(13):5166-5171.
27. Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2 [J]. Proc Natl Acad Sci U S A, 2005,102(39):13944-13949.
28. He L, Thomson JM, Hemann MT, et al. A microRNA polycistron as a potential human oncogene [J]. Nature, 2005,435(7043):828-833.
29. Mendell JT. miRiad roles for the miR-17 -92 cluster in development and disease [J]. Cell, 2008,133(2):217-222.
30. Costinean S, Zanesi N, Pekarsky Y, et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-m iR155 transgenic mice [J]. Proc Natl Acad Sci U S A, 2006,103(18):7024-7029.
31. Thai TH, Calado DP, Casola S, et al. Regulation of the germinal center response by microRNA-15 5 [J]. Science, 2007,316(5824):604-608.
32. Rodriguez A, Vigorito E, Clare S, et al. Requirement of bic/ microRNA-15 5 for normal immune function [J]. Science, 2007,316(5824):608-611.
33. Tili E, Michaille JJ, Cimino A, et al. Modulation of miR-15 5 and miR-12 5b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock [J]. J Immunol, 2007,179(8):5082-5089.
34. Cully M, You H, Levine AJ, et al. Beyond PTEN mutations: The PI3K pathway as an integrator of multiple inputs during tumorigenesis [J]. Nat Rev Cancer, 2006,6(3):184-192.
35. Meng F, Henson R, Wehbe-Janek H, et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer [J]. Gastroenterology, 2007,133 (2):647-658.
36. Asangani IA, Rasheed SA, Nikolova DA, et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer [J]. Oncogene, 2008,27(15):2128-2136.
37. Frankel LB, Christoffersen NR, Jacobsen A, et al. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells [J]. J Biol Chem, 2008,283(2):1026-1033.
38. Pineau P, Volinia S, McJunkin K, et al. miR-22 1 overexpression contributes to liver tumorigenesis [J]. Proc Natl Acad Sci U S A, 2010,107(1):264-269.
39. Felli N, Fontana L, Pelosi E, et al. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation [J]. Proc Natl Acad Sci U S A, 2005,102(50):18081-18086.
40. Calin GA, Ferracin M, Cimmino A, et al. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia [J]. N Engl J Med, 2005,353 (17):1793-1801.
41. Raveche ES, Salerno E, Scaglione BJ, et al. Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice [J]. Blood, 2007,109(12):5079-5086.
42. Shen J, Ambrosone CB, Zhao H. Novel genetic variants in microRNA genes and familial breast cancer [J]. Int J Cancer, 2009,124(5):1178-1182.
43. Pelletier C, Weidhaas JB. MicroRNA binding site polymorphisms as biomarkers of cancer risk [J]. Expert Rev Mol Diagn,10(6):817-829.
44. Song FJ, Chen KX. Single-nucleotide polymorphisms among microRNA: big effects on cancer [J]. Chin J Cancer,30 (6): 381-391.
45. Fabbri M, Valeri N, Calin GA. MicroRNAs and genomic variations: from proteus tricks to prometheus gift [J]. Carcinogenesis, 2009,30(6):912-917.
46. Song F, Zheng H, Liu B, et al. An miR-50 2-binding site single- nucleotide polymorphism in the 3'-un translated region of the SET8 gene is associated with early age of breast cancer onset [J]. Clin Cancer Res, 2009,15(19):6292-6300.
47. Zheng H, Song F, Zhang L, et al. Genetic variants at the miR- 124 binding site on the cytoskeleton-organizing IQGAP1 gene confer differential predisposition to breast cancer [J]. Int J Oncol, 2011,38(4):1153-1161.
48. Garzon R, Garofalo M, Martelli MP, et al. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin [J]. Proc Natl Acad Sci U S A, 2008,105(10):3945-3950.
49. Schetter AJ, Leung SY, Sohn JJ, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma [J]. JAMA, 2008,299(4):425-436.
50. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers [J]. Nature, 2005,435(7043):834-838.
51. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection [J]. Proc Natl Acad Sci U S A, 2008,105(30):10513-10518.
52. Zhang HL, Yang LF, Zhu Y, et al. Serum miRNA-21: elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy [J]. Prostate, 2011,71(3):326-331.
53. Boeri M, Verri C, Conte D, et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer [J]. Proc Natl Acad Sci U S A, 2011,108(9):3713-3718.
54. Cheng H, Zhang L, Cogdell DE, et al. Circulating plasma miR- 141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis [J]. PLoS ONE, 2011,6(3):e17745.
55. Spizzo R, Rushworth D, Guerrero M, et al. RNA inhibition, microRNAs, and new therapeutic agents for cancer treatment [J]. Clin Lymphoma Myeloma, 2009,9:S313-S318.
56. Rupaimoole R, Han HD, Lopez-Berestein G, et al. MicroRNA therapeutics: principles, expectations, and challenges [J]. Chin J Cancer, 2011,30(6):368-370.
57. Cheson BD. Oblimersen for the treatment of patients with chronic lymphocytic leukemia [J]. Ther Clin Risk Manag, 2007,3(5):855-870.
58. Ravasi T, Suzuki H, Pang KC, et al. Experimental validation of the regulated expression of large numbers of non-coding RNAs from the mouse genome [J]. Genome Res, 2006,16(1):11-19.
59. Furuno M, Pang KC, Ninomiya N, et al. Clusters of internally primed transcripts reveal novel long noncoding RNAs [J]. PLoS Genet, 2006,2(4):e37.
60. Mattick JS. The genetic signatures of noncoding RNAs [J]. PLoS Genet, 2009,5(4):e1000459.
61. Gupta RA, Shah N, Wang KC, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis [J]. Nature, 2010,464(7291):1071-1076.
62. Calin GA, Liu CG, Ferracin M, et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas [J]. Cancer Cell, 2007,12(3):215-229.
63. Jacob F, Monod J. Genetic regulatory mechanisms in the synthesis of proteins [J]. J Mol Biol, 1961,3:318-356.
64. Britten RJ, Davidson EH. Gene regulation for higher cells: a theory [J]. Science, 1969,165(891):349-357.
65. Taft RJ, Pheasant M, Mattick JS. The relationship between non- protein-co ding DNA and eukaryotic complexity [J]. Bioessays, 2007,29(3):288-299.
66. Birney E, Stamatoyannopoulos JA, Dutta A, et al. Identification and analysis of functional elements in 1% of the human genome by the encode pilot project [J]. Nature, 2007,447 (7146):799-816.
67. Kapranov P, Willingham AT, Gingeras TR. Genome-wide transcription and the implications for genomic organization [J]. Nat Rev Genet, 2007,8(6):413-423.
68. Carninci P, Kasukawa T, Katayama S, et al. The transcriptional landscape of the mammalian genome [J]. Science, 2005,309 (5740):1559-1563.
69. Mercer TR, Dinger ME, Sunkin SM, et al. Specific expression of long noncoding RNAs in the mouse brain [J]. Proc Natl Acad Sci U S A, 2008,105(2):716-721.